Home

 

Investor Relations

SGMO - (NASD)

$10.04   - 0.22

Jul 3, 2008

1:14 PM ET



Corporate Profile

Sangamo BioSciences, Inc. is the worldwide leader in the research, development and commercialization of engineered zinc finger DNA-binding proteins for therapeutic gene regulation and therapeutic gene correction. Our technology platform has multiple applications in human therapeutics and drug discovery.

Copyright © 2008 Sangamo BioSciences, Inc.